NTBLQ — Notable Labs Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.79m
- $0.31m
Annual balance sheet for Notable Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 36.5 | 30.3 | 53.1 | 20.7 | 11.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.629 | 0.322 | 0.465 | 0.102 | 0.186 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 37.8 | 32 | 54.8 | 22.1 | 15.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10.1 | 8.76 | 8.86 | 7.14 | 2.35 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 49 | 41.7 | 64.7 | 29.7 | 19.5 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.67 | 7.46 | 9.93 | 6.73 | 2.74 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 13 | 10.8 | 12.5 | 7.21 | 4.43 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 36 | 30.9 | 52.2 | 22.5 | 15.1 |
| Total Liabilities & Shareholders' Equity | 49 | 41.7 | 64.7 | 29.7 | 19.5 |
| Total Common Shares Outstanding |